Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05639088 · ClinicalTrials.gov registry record · NA
Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes
A NA study of Type 1 Diabetes, sponsored by Virginia Commonwealth University.
- Active
- Registry status
- NA
- Development phase
- 109
- Enrollment target
- 1
- Study location
NCT05639088: Active NA study of Type 1 Diabetes, sponsored by Virginia Commonwealth University.
NCT05639088 is a NA study of Type 1 Diabetes that is active but no longer recruiting, run by Virginia Commonwealth University. The registered enrollment target is 109 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05639088, a NA study of Type 1 Diabetes, is active but no longer recruiting, sponsored by Virginia Commonwealth University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also include a caregiver. Results from this study will inform clinical recommendations regarding self-management best practices for AYAs with T1D prior to transitioning to adult medical care.
Primary Outcome
HbA1C will be assessed using a standard assay from a routine blood draw or an at-home testing kit
Conditions Studied
Interventions
- OTHER Educational materials
- BEHAVIORAL Transition preparation program
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2023-08-24 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05639088 still lists
NCT05639088 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Educational materials is the first listed.
NCT05639088 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05639088 about?
NCT05639088 is a clinical study titled "Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes". The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also inc...
What is the current status of trial NCT05639088?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 109 participants. The study started on 2023-08-24. Estimated completion is 2026-12-31.
What conditions does trial NCT05639088 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT05639088?
The interventions under investigation include: Educational materials (OTHER), Transition preparation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05639088?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05639088 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05639088's enrollment target sits among peer trials
109 52nd of 198 higher than 147 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI